Comment from Coalition for Healthcare Communication
The is a Comment on the Food and Drug Administration (FDA) Notice: Draft Guidance for Industry on Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media for Prescription Human and Animal Drugs and Biologics; Availability
For related information, Open Docket Folder
The attached comment is being submitted on behalf of the Coalition for Healthcare Communication.
No documents available.
| || |
Comment Period Closed
Apr 14 2014, at 11:59 PM ET
Tracking Number: 1jy-8bf6-tdkf
Show More Details
Date Posted: Apr 15, 2014
Submitter's Representative: John Kamp
Category: Drug Association - D0012